EVRG vs LAB · P/E 22, rev $5.85B vs rev $174.4M
Evergy, Inc. (EVRG) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported EVRG revenue for 2024-12-31 was $5.85B. Net income was $885.8M. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
EVRG currently screens at market cap $19.10B and trailing P/E 22.0. LAB currently screens at market cap $317.1M.
Not investment advice. Open the EVRG and LAB stock pages for the full models.
Not investment advice.